Bioactivity:

MYLS22 is a first-in-class and selective inhibitor of optic atrophy 1 (OPA1) .�MYLS22 can target endothelial OPA1 to curtail tumor growth and inhibits angiogenesis by impinging on NFkB activity and on angiogenic gene expression.�It�with anti-angiogenesis

CAS nr:

306959-01-3

Purity:

98%

Molecular Weight:

443,52

SMILES:

Cc(c1c2sc(C(NC(C3=O)=C(C)N(C)N3c3ccccc3)=O)c1)nn2-c1ccccc1

Formula:

C24H21N5O2S

Pathway:

Others

Target:

Others